IFIH1 and breast carcinoma: Similar findings were shown in 9-cis-retinoic-acid (9cRA) treatment of SK-BR-3 breast cancer cells, which revealed no significant change of TLR3, MDA5 and PKR, but significant up-regulation of RIG-I.